IL-33 诱导一种保护性反应,防止刺激物诱导的气道炎症和功能障碍
Utako Fujii1,2, Tomotaka Nishizawa1,2, Yumiko Ishii1,2
1Meakins-Christie Laboratories, McGill University Health Centre Research Institute, Montreal, Quebec, Canada; and.
概括
介素-33 (IL-33) 激活先天性淋巴细胞 (ILCs),以防止呼吸道功能障碍和因吸入气引起的炎症,涉及IL-13和巨细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 毒理学 毒理学 毒理学
背景情况:
- 干白素-33 (IL-33) 和先天性淋巴细胞 (ILC) 涉及2型 (T2) 高喘.
- IL-33和ILCs在刺激诱导的呼吸道功能障碍中的作用尚不清楚.
研究的目的:
- 研究 (Cl2) 吸入对IL-33释放,肺部ILCs,呼吸道炎症和呼吸道过敏反应 (AHR) 的影响.
主要方法:
- 鼠被暴露在Cl2和IL-33释放中,ILC种群,呼吸道炎症和AHR被评估.
- 研究涉及IL-33受体抑制,ILC枯竭,以及再组合IL-33,IL-13或克洛德罗纳酸脂质体的使用.
主要成果:
- 暴露于Cl2会增加小鼠呼吸道中的IL-33释放和ILC2s.
- 给予IL-33抑制了Cl2诱导的中性恋和AHR,这种效果取决于ILCs.
- IL-33促进了IL-2s的IL-13产生,使巨细胞偏向M2表型,而IL-13则介导了对AHR的保护作用.
结论:
- 由IL-33驱动的ILC2s扩张激活了一条涉及IL-13和巨细胞的保护通路,防止Cl2诱导的气道功能障碍和炎症.
相关概念视频
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


